POSTERS ASCO 2024

Terapias en desarrollo

Inmunoterapia

Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.

Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.

Abstract: 2550 Poster Bd #: 29

Poster

Descargar

Autor
Javier Arroyo-Rodenas, PharmD, MSc

Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON